Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/5/26 Zealand Pharma (ZEAL) petrelintide for Obesity Subscribers Only Subscribers Only Subscribers Only
6/5/26 Memo Therapeutics potravitug for Antiviral - Other Treatments Subscribers Only Subscribers Only Subscribers Only
6/3/26 ADC Therapeutics (ADCT) Zynlonta for Diffuse Large B-Cell Lymphoma (DLBCL) Subscribers Only Subscribers Only Subscribers Only
6/3/26 Roche (RO) Zelboraf for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only
6/3/26 Shanghai Kechow Pharma tunlametinib for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/31/2023 Subscribers Only Subscribers Only Trial Announcement - Initiation
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update